BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14998517)

  • 1. Expression of staphylococcal clumping factor A impedes macrophage phagocytosis.
    Palmqvist N; Patti JM; Tarkowski A; Josefsson E
    Microbes Infect; 2004 Feb; 6(2):188-95. PubMed ID: 14998517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clumping factor A-mediated virulence during Staphylococcus aureus infection is retained despite fibrinogen depletion.
    Palmqvist N; Josefsson E; Tarkowski A
    Microbes Infect; 2004 Feb; 6(2):196-201. PubMed ID: 14998518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.
    Josefsson E; Hartford O; O'Brien L; Patti JM; Foster T
    J Infect Dis; 2001 Dec; 184(12):1572-80. PubMed ID: 11740733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
    Tkaczyk C; Hamilton MM; Sadowska A; Shi Y; Chang CS; Chowdhury P; Buonapane R; Xiao X; Warrener P; Mediavilla J; Kreiswirth B; Suzich J; Stover CK; Sellman BR
    mBio; 2016 Jun; 7(3):. PubMed ID: 27353753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes.
    Higgins J; Loughman A; van Kessel KP; van Strijp JA; Foster TJ
    FEMS Microbiol Lett; 2006 May; 258(2):290-6. PubMed ID: 16640587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection.
    Scully IL; Timofeyeva Y; Keeney D; Matsuka YV; Severina E; McNeil LK; Nanra J; Hu G; Liberator PA; Jansen KU; Anderson AS
    Vaccine; 2015 Oct; 33(41):5452-5457. PubMed ID: 26319743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phagocytosis.
    Hair PS; Echague CG; Sholl AM; Watkins JA; Geoghegan JA; Foster TJ; Cunnion KM
    Infect Immun; 2010 Apr; 78(4):1717-27. PubMed ID: 20100856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capsular polysaccharide masks clumping factor A-mediated adherence of Staphylococcus aureus to fibrinogen and platelets.
    Risley AL; Loughman A; Cywes-Bentley C; Foster TJ; Lee JC
    J Infect Dis; 2007 Sep; 196(6):919-27. PubMed ID: 17703424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A.
    Narita K; Hu DL; Mori F; Wakabayashi K; Iwakura Y; Nakane A
    Infect Immun; 2010 Oct; 78(10):4234-42. PubMed ID: 20679443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of Staphylococcus aureus Coagulases and Clumping Factor A to Abscess Formation in a Rabbit Model of Skin and Soft Tissue Infection.
    Malachowa N; Kobayashi SD; Porter AR; Braughton KR; Scott DP; Gardner DJ; Missiakas DM; Schneewind O; DeLeo FR
    PLoS One; 2016; 11(6):e0158293. PubMed ID: 27336691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New potential role of serum apolipoprotein E mediated by its binding to clumping factor A during Staphylococcus aureus invasive infections to humans.
    Elkhatib WF; Hair PS; Nyalwidhe JO; Cunnion KM
    J Med Microbiol; 2015 Apr; 64(Pt 4):335-343. PubMed ID: 25878259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure.
    Hawkins J; Kodali S; Matsuka YV; McNeil LK; Mininni T; Scully IL; Vernachio JH; Severina E; Girgenti D; Jansen KU; Anderson AS; Donald RG
    Clin Vaccine Immunol; 2012 Oct; 19(10):1641-50. PubMed ID: 22896688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
    Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB
    PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic elimination of the binding motif on fibrinogen for the S. aureus virulence factor ClfA improves host survival in septicemia.
    Flick MJ; Du X; Prasad JM; Raghu H; Palumbo JS; Smeds E; Höök M; Degen JL
    Blood; 2013 Mar; 121(10):1783-94. PubMed ID: 23299312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial action of extracellular mammalian group IIA phospholipase A2 against grossly clumped Staphylococcus aureus.
    Dominiecki ME; Weiss J
    Infect Immun; 1999 May; 67(5):2299-305. PubMed ID: 10225887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence.
    Josefsson E; Higgins J; Foster TJ; Tarkowski A
    PLoS One; 2008 May; 3(5):e2206. PubMed ID: 18493318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive Upregulation of Clumping Factor A (ClfA) by Staphylococcus aureus in the Obese, Type 2 Diabetic Host Mediates Increased Virulence.
    Farnsworth CW; Schott EM; Jensen SE; Zukoski J; Benvie AM; Refaai MA; Kates SL; Schwarz EM; Zuscik MJ; Gill SR; Mooney RA
    Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28320836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach.
    Tkaczyk C; Kasturirangan S; Minola A; Jones-Nelson O; Gunter V; Shi YY; Rosenthal K; Aleti V; Semenova E; Warrener P; Tabor D; Stover CK; Corti D; Rainey G; Sellman BR
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.
    Veloso TR; Mancini S; Giddey M; Vouillamoz J; Que YA; Moreillon P; Entenza JM
    Vaccine; 2015 Jul; 33(30):3512-7. PubMed ID: 26048778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureus.
    Nour El-Din AN; Shkreta L; Talbot BG; Diarra MS; Lacasse P
    Vaccine; 2006 Mar; 24(12):1997-2006. PubMed ID: 16426711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.